1. Home
  2. OSPN vs ORGO Comparison

OSPN vs ORGO Comparison

Compare OSPN & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$11.36

Market Cap

449.1M

Sector

Technology

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$3.76

Market Cap

514.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
ORGO
Founded
1991
1985
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
514.0M
IPO Year
2000
2016

Fundamental Metrics

Financial Performance
Metric
OSPN
ORGO
Price
$11.36
$3.76
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$17.00
$8.00
AVG Volume (30 Days)
693.4K
482.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.31%
N/A
EPS Growth
297.30
N/A
EPS
0.76
N/A
Revenue
$243,179,000.00
$482,043,000.00
Revenue This Year
$0.69
$8.14
Revenue Next Year
$1.96
$6.33
P/E Ratio
$14.66
N/A
Revenue Growth
3.43
11.29
52 Week Low
$10.17
$2.61
52 Week High
$18.13
$7.08

Technical Indicators

Market Signals
Indicator
OSPN
ORGO
Relative Strength Index (RSI) 48.42 41.74
Support Level $11.00 $3.66
Resistance Level $12.21 $5.08
Average True Range (ATR) 0.45 0.18
MACD 0.05 0.04
Stochastic Oscillator 69.23 20.83

Price Performance

Historical Comparison
OSPN
ORGO

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: